ATLANTA, Feb. 16, 2017 -- Hatch Medical, L.L.C., a medical device incubator and technology brokerage firm, announced today that it has entered into an agreement with MUCOM, L.L.C. to broker the sale or license of its patented male urinary incontinence device MUI Comfort™.
MUI Comfort™ is an integrated external collection system that meets the needs of a growing demographic that is coping with the consequences of stress, urge, and overflow incontinence. This innovative technology is differentiated from competing products by providing a complete solution that addresses both functional and psychological aspects associated with male urinary incontinence. MUI Comfort™ has several elements that are central to its patented design including:
- A lightweight collection bag with an integrated drainage neck and secured opening.
- A soft inner liner to protect the skin from perspiration and potential allergenic reaction.
- An enlarged opening with an adjustable closure mechanism that is part of three key elements that prevent accidental leaks, protect the skin, and provide secure fixation.
- A wicking component that draws urine into a superabsorbent-deodorizing polymer and will bond with any liquid to minimize odor, prevent sloshing and leakage.
- Watch the video
“We are excited to be working with the MUCOM team and representing such innovative technology that can provide millions of effected men with a superior management option for their stress, urge, and overflow incontinence,” commented Paul Gianneschi, Managing Principal at Hatch Medical L.L.C.
Donna Lou DuPree McCormack, RN, BSN, President of MUCOM, LLC commented, “We are excited to offer this innovative technology to countless men who are subjected to the embarrassment and social isolation of urinary incontinence, who have been underserved by disappointing products. Our patented technology has the potential to enhance the wellness and quality of life for untold millions of males as they eliminate the use of diapers and pads. We are delighted to be working with Hatch Medical to bring this new technology to the market.”
Founded in 2000, Hatch Medical is an incubator and broker of medical device technologies, assisting clients with development, licensing, distribution and asset sales. For information on this, or other Hatch Medical, L.L.C. products and services, email the company at [email protected]. This release and additional news about Hatch Medical can be obtained by visiting the company’s web site -- http://www.hatchmedical.com.
Contact Paul Gianneschi, Managing Principal, 770-476-9940, Steve Hvozda, Principal 949-388-9335, or Gary Robinson 215-353-0362


Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Instagram Outage Disrupts Thousands of U.S. Users
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



